The Phase III trial is a randomized, placebo-controlled, double-blinded study of XL184 as single-agent therapy in 315 patients with unresectable, locally advanced, or metastatic medullary thyroid cancer (MTC).
Graceptor is a once-daily modified release formulation of Astella’s Prograf (tacrolimus, twice-daily formulation). Tacrolimus works as an immunosuppressant by inhibiting production of cytokinine including differentiation or growth factor
The agreement provides for a payment to Biota of A$20 million, with each party bearing their own litigation costs. The payment will be made on August 18, 2008.
The patent grant ensures that the novel disposable cassette system and the key elements of the detection technology employed in Afinion are protected from copying by third parties.
According to the company, the weight control group – which markets Alli diet pills – and the smoking cessation group – which includes the NicoDerm, Nicorette and Commit
Under the current system, the use of unauthorized medicines or the off-label prescribing of an authorized drug must be approved by the Spanish medicines agency, AEMPS, on a
Proteoderm has created an anti-aging and anti-wrinkle product line that is said to enhance the skin’s firmness and elasticity and promotes the skin’s natural moisture production activity. Unlike
The market launch in Germany is delayed preliminarily because the originator firm Sanofi-Aventis has challenged the approval as has been expected. For the time being, this prevents the
Impliant’s Tops spine system less-invasive version features a reduced L5 crossbar configuration that the company feels will further reduce tissue retraction and operative time during Tops implantation. Impliant
Under the cooperative R&D agreement, the collaboration will leverage Calibrant’s unique proteomic technologies for the purposes of evaluating and validating protein markers for a variety of major, unmet
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.